MedPacto, Inc. (KOSDAQ:235980)
South Korea · Delayed Price · Currency is KRW 4,590.00
-75.00 (-1.61%)
Sep 19, 2025, 3:30 PM KST
MedPacto Market Cap
MedPacto has a market cap or net worth of 157.32 billion as of September 19, 2025. Its market cap has decreased by -34.02% in one year.
Market Cap
157.32B
Enterprise Value
110.92B
Revenue
1.27B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,590.00
Market Cap Chart
Since December 19, 2019, MedPacto's market cap has decreased from 362.50B to 157.32B, a decrease of -56.60%. That is a compound annual growth rate of -13.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2025 | 157.32B | 3.49% |
| Dec 30, 2024 | 152.01B | -37.48% |
| Dec 28, 2023 | 243.12B | -48.17% |
| Dec 29, 2022 | 469.05B | -60.97% |
| Dec 30, 2021 | 1,201.91B | -49.78% |
| Dec 30, 2020 | 2,393.41B | 435.67% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.88T |
| Celltrion | 37.63T |
| ALTEOGEN | 25.25T |
| SK Biopharmaceuticals | 8,888.55B |
| Yuhan | 8,872.07B |
| Peptron | 6,750.37B |
| PharmaResearch | 6,202.62B |
| ABL Bio | 5,910.48B |